Blair Health, a Toronto-based clinical infrastructure company focused on women's health, has secured CAD $4.24 million in pre-seed financing, marking its first institutional round. The oversubscribed investment brings the company's total funding to CAD $4.5 million and was co-led by BDC's Thrive Venture Fund, Accelia Capital, and Ogaei. The new capital will support product development, commercial expansion in Canada and the United States, and growth of its clinical operations and provider network.
Closing the Specialist Access Gap
Blair Health was founded in December 2024 by Chief Executive Officer Madge Rumman and Chief Medical Officer Dr. Lindsay Shirreff. The company addresses one of the most persistent challenges in women's health: long waits for specialist appointments, particularly in areas such as menopause. Its proprietary clinical models encode specialist-designed care pathways so that generalist providers can deliver specialist-level treatment within days rather than months or years.
Clinical Model and Early Validation
The platform is built with medical subspecialists who translate assessment logic, treatment protocols, escalation triggers, and follow-up pathways into software. Blair's in-house nurse practitioners and family physicians then use these tools to provide care, with subspecialists overseeing complex cases. The company reports that its menopause pathway performs at 98.7 percent clinical accuracy and can be taught to a provider in under four hours.
From Menopause to Multiple Specialties
The company first proved its model in menopause, a field where Canadian women can wait up to two years for specialist care. Its menopause pathway was built with Dr. Shirreff, a fellowship-trained subspecialist, and was clinically validated against Blair's own data before launch. The architecture has since been extended into urology, pelvic health, and clinical nutrition, demonstrating that the technology can support multiple areas of medicine.
A Scalable Model for Specialty Care
Chief Executive Officer Madge Rumman said the traditional model for delivering specialist care does not scale. The company spent the last year proving that specialist knowledge can be encoded into technology without removing clinicians from care. She added that the same architecture can be applied across specialties where backlogs are greatest and subspecialists are scarce.
National Reach and User Growth
Since its direct-to-consumer launch in May 2025, Blair has signed up more than 2,300 women and now operates in every Canadian province with service in English and French. The company has also expanded into six U.S. states, with more to come, and between 55 and 65 percent of steady-state visits are follow-ups. This pattern reflects a longitudinal care model rather than one-off consultations.
Employer Channel Gains Momentum
Blair's employer offering has become a significant revenue driver, moving from near zero a year ago to roughly half of revenue in the first half of 2026. Pilots with organizations in professional services, hospitality, and financial services have converted into recurring annual contracts. Fairmont Royal York, one early adopter, reported that the program gave colleagues timely access to specialist care and had a meaningful impact on wellbeing and workplace experience.
Investor Confidence
Investors describe Blair Health as responding to one of the largest underserved opportunities in healthcare. Roxanne Turcotte, Senior Vice President at BDC, said the investment reflects a commitment to backing women-led companies with strong growth potential. Catherine Poulin-Filion, Partner at Accelia Capital, noted that the team is rethinking how care is delivered rather than simply digitizing an existing model.
Blair Health plans to use the funding to accelerate engineering, expand its U.S. employer business, and collaborate with public-sector health systems in Canada. The company's approach combines clinical oversight with technology to address specialist shortages and improve timely access to care for women. With early commercial traction, expanding clinical verticals, and a growing employer channel, Blair is positioning itself as a new category of healthcare infrastructure.